Table 1.

FZD administration during acute FIV infection temporarily reduces plasma viremia.

	(FIV-gag-mRNA [copies/mL plasma]) Week Postinfection (PI)
	2	4	6
FZD
Positive (%)	17	83	100
Mean	167	12,918	6,891
Median	0	4,767	8,691
Range	0–1,000	0–53,271	0–9,604
Placebo
Positive (%)	100	100	100
Mean	17,385	35,390	19,991
Median	1,574	20,361	12,752
Range	1,000–73,809	7,766–98,786	1,000–62,529
P-value	.015*	NS	NS

The percentage of positive cats by PCR analysis is shown in the first row for FZD- and placebo-treated groups. The mean, median, and range of the number of virus copies/mL are listed for each cat at 2, 4, and 6 weeks PI. P < .05.

FIV, feline immunodeficiency virus; FZD, fozivudine; NS, not significant.